Abstract:Early detection of cancer is crucial to reducing fatalities and improving patient outcomes. Metastasis is the first stage of aggressive cancers, often occurring before primary lesions can be seen. It occurs when cancerous cells disseminate to distant, non-malignant organs through the bloodstream, known as circulating tumor cells (CTCs). CTCs, or cancer tumor cells, are valuable indicators for predicting treatment response, metastasis progression, and disease progression. However, they are primarily used for research due to challenges like heterogeneity, separation from blood, and lack of clinical validation. Only a few methods have been approved for clinical use. One area of research is the isolation and identification of CTCs, which could significantly impact early cancer detection and prognosis. Current technologies using whole-blood samples use size, immunoaffinity, and density approaches, along with positive and negative enrichment techniques. Surface modification of nanomaterials is important for effective cancer therapies because it improves their ability to target and reduces interactions with healthy tissues. Consequently, researchers have created biomimetic nanoparticles covered with cell membranes using functional, targeted, and biocompatible coating technology. Nanoparticles with membranes can target specific cells, stay in circulation for longer, and avoid immune responses, which makes them much better at capturing CTCs. This study examines the current opportunities and difficulties associated with using cell membrane–coated nanoparticles as a capture technique for CTCs. In addition, we examine potential future developments in light of the current obstacles and investigate areas that require further research to fully understand its growing clinical possibilities.

Advances on the Relationship Between Plasma Membrane Protein and Tumor

Rearch Progress on the Relationship Between Mast Cells and Cancer

Multifaceted roles of exosomes in epithelial-mesenchymal transition and tumor metastasis

Perturbing plasma membrane lipid: a new paradigm for tumor nanotherapeutics

Cell membrane-coated nanomaterials for cancer therapy

Progress of research on the relationship between efferocytosis and tumor

Membrane-Coated Biomimetic Nanoparticles: A State-of-the-Art Multifunctional Weapon for Tumor Immunotherapy

Progress in Study of Matrix Metalloproteinases and Tumour Invasion and Metastasis

Advances in the role of membrane-bound transcription factors in carcinogenesis and therapy

Research progress of cell membrane biomimetic nanoparticles for circulating tumor cells

Application of Cell Membrane-Coated Nanomaterials for Tumor Treatment.

Extracellular Vesicles: A New Perspective in Tumor Therapy

Research Progress on Relationship Between Complement Activation and Tumor Immunity

Tumor-Derived Extracellular Vesicles: Their Role in Immune Cells and Immunotherapy

Semaphorins in tumor microenvironment: Biological mechanisms and therapeutic progress

Role of tumor microenvironment in cancer progression and therapeutic strategy

The Relationship between Mesenchymal Stem Cells and Tumor

Membrane protein trafficking in the anti-tumor immune response: work of endosomal-lysosomal system

Research Progress on the Relationship Between ANGPT-TIE Signal System and Development of Tumor

Cell Adhesion Molecules in Tumor Development and Progression

Exosomal Micrornas Shuttling Between Tumor Cells and Macrophages: Cellular Interactions and Novel Therapeutic Strategies